Emergency Medicine in Cardiovascular Diseases

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Emergency Medicine".

Deadline for manuscript submissions: 22 October 2024 | Viewed by 1503

Special Issue Editors


E-Mail Website
Guest Editor
Emergency Unit, Azienda Ospedaliero-Universitaria “Ospedali Riuniti”, 60126 Ancona, Italy
Interests: emergency medicine; sepsis; cardiopulmonary resuscitation; emergency management; emergency treatment

E-Mail Website
Guest Editor
Cardiology and Arrhythmology Clinic, University Hospital “Umberto I-Lancisi-Salesi”, Marche Polytechnic University, 60123 Ancona, Italy
Interests: clinical cardiology; statistics; cardiovascular medicine; atrial fibrillation; blood pressure; echocardiography; heart failure; hypertension; myocardial infarction; electrophysiology

E-Mail Website
Guest Editor
Head ICCU, Cardiology Division, Cardiovascular Department, Azienda Ospedaliero Universitaria delle Marche, 60126 Ancona, Italy
Interests: acute heart failure; acute coronary syndrome; chronic heart failure; clinical registries; RCTs
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The way to provide the right care for the right patient at the right time in contemporary overcrowded Emergency Departments is a major topic. This is particularly true in the management of the acute phase of cardiovascular diseases. An increasing number of accurate strategies have been designed in order to optimize the determination of acute coronary syndrome or pulmonary embolism in case of chest pain. The role of the Emergency Department Observation Unit and structural protocols has been studied to better manage patients with acute heart failure or pericarditis. Moreover, the acute aortic syndrome remains a challenge for Emergency physicians. In this Special Issue, we welcome authors to submit papers on the management of arrhythmias, acute coronary syndrome, pulmonary embolism, acute heart failure, pericarditis and acute aortic syndrome in the Emergency Department in terms of both diagnosis and treatment.

Dr. Vincenzo G. Menditto
Dr. Federico Guerra
Dr. Marco Marini
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • arrhythmias
  • atrial fibrillation
  • acute coronary syndrome
  • myocardial infarction
  • sudden cardiac death
  • cardiogenic shock
  • pulmonary embolism
  • heart failure
  • pericarditis
  • acute aortic syndrome
  • aortic dissection
  • emergency department
  • observation unit
  • biomarkers
  • echocardiography

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

13 pages, 850 KiB  
Article
Evolution of Cardiogenic Shock Management and Development of a Multidisciplinary Team-Based Approach: Ten Years Experience of a Single Center
by Leonardo Belfioretti, Matteo Francioni, Ilaria Battistoni, Luca Angelini, Maria Vittoria Matassini, Giulia Pongetti, Matilda Shkoza, Luca Piangerelli, Tommaso Piva, Elisa Nicolini, Alessandro Maolo, Andi Muçaj, Paolo Compagnucci, Christopher Munch, Antonio Dello Russo, Marco Di Eusanio and Marco Marini
J. Clin. Med. 2024, 13(7), 2101; https://doi.org/10.3390/jcm13072101 - 3 Apr 2024
Viewed by 619
Abstract
Background: The management of cardiogenic shock (CS) after ACS has evolved over time, and the development of a multidisciplinary team-based approach has been shown to improve outcomes, although mortality remains high. Methods: All consecutive patients with ACS-CS admitted at our CICU from March [...] Read more.
Background: The management of cardiogenic shock (CS) after ACS has evolved over time, and the development of a multidisciplinary team-based approach has been shown to improve outcomes, although mortality remains high. Methods: All consecutive patients with ACS-CS admitted at our CICU from March 2012 to July 2021 were included in this single-center retrospective study. In 2019, we established a “shock team” consisting of a cardiac intensivist, an interventional cardiologist, an anesthetist, and a cardiac surgeon. The primary outcome was in-hospital mortality. Results: We included 167 patients [males 67%; age 71 (61–80) years] with ischemic CS. The proportion of SCAI shock stages from A to E were 3.6%, 6.6%, 69.4%, 9.6%, and 10.8%, respectively, with a mean baseline serum lactate of 5.2 (3.1–8.8) mmol/L. Sixty-six percent of patients had severe LV dysfunction, and 76.1% needed ≥ 1 inotropic drug. Mechanical cardiac support (MCS) was pursued in 91.1% [65% IABP, 23% Impella CP, 4% VA-ECMO]. From March 2012 to July 2021, we observed a significative temporal trend in mortality reduction from 57% to 29% (OR = 0.90, p = 0.0015). Over time, CS management has changed, with a significant increase in Impella catheter use (p = 0.0005) and a greater use of dobutamine and levosimendan (p = 0.015 and p = 0.0001) as inotropic support. In-hospital mortality varied across SCAI shock stages, and the SCAI E profile was associated with a poor prognosis regardless of patient age (OR 28.50, p = 0.039). Conclusions: The temporal trend mortality reduction in CS patients is multifactorial, and it could be explained by the multidisciplinary care developed over the years. Full article
(This article belongs to the Special Issue Emergency Medicine in Cardiovascular Diseases)
Show Figures

Graphical abstract

Review

Jump to: Research

12 pages, 755 KiB  
Review
The Use of Thrombectomy during Primary Percutaneous Coronary Intervention: Resurrecting an Old Concept in Contemporary Practice
by Zahir Satti, Muntaser Omari, Bilal Bawamia, Timothy Cartlidge, Mohaned Egred, Mohamed Farag and Mohammad Alkhalil
J. Clin. Med. 2024, 13(8), 2291; https://doi.org/10.3390/jcm13082291 - 15 Apr 2024
Viewed by 541
Abstract
Optimal myocardial reperfusion during primary percutaneous coronary intervention (pPCI) is increasingly recognized to be beyond restoring epicardial coronary flow. Both invasive and non-invasive tools have highlighted the limitation of using this metric, and more efforts are focused towards achieving optimal reperfusion at the [...] Read more.
Optimal myocardial reperfusion during primary percutaneous coronary intervention (pPCI) is increasingly recognized to be beyond restoring epicardial coronary flow. Both invasive and non-invasive tools have highlighted the limitation of using this metric, and more efforts are focused towards achieving optimal reperfusion at the level of the microcirculation. Recent data highlighted the close relationship between thrombus burden and impaired microcirculation in patients presenting with ST-segment elevation myocardial infarction (STEMI). Moreover, distal embolization was an independent predictor of mortality in patients with STEMI. Likewise, the development of no-reflow phenomenon has been directly linked with worse clinical outcomes. Adjunctive thrombus aspiration during pPCI is intuitively intended to remove atherothrombotic material to mitigate the risk of distal embolization and the no-reflow phenomenon (NRP). However, prior trials on the use of thrombectomy during pPCI did not support its routine use, with comparable clinical endpoints to patients who underwent PCI alone. This article aims to review the existing literature highlighting the limitation on the use of thrombectomy and provide future insights into trials investigating the role of thrombectomy in contemporary pPCI. Full article
(This article belongs to the Special Issue Emergency Medicine in Cardiovascular Diseases)
Show Figures

Figure 1

Back to TopTop